Critical role of the CD40-CD40-ligand pathway in regulating mucosal inflammation-driven angiogenesis in inflammatory bowel disease

Danese, S.; Scaldaferri, F.; Vetrano, S.; Stefanelli, I.; Graziani, C.; Repici, A.; Ricci, R.; Straface, G.; Sgambato, A.; Malesci, A.; Fiocchi, C.; Rutella, S.
September 2007
Gut;Sep2007, Vol. 56 Issue 9, p1248
Academic Journal
Background and aims: Angiogenesis is a novel component in inflammatory bowel disease (IBD) pathogenesis. We have previously shown that immune-nonimmune interactions through the CD40-CD40-ligand (CD40L) pathway might sustain gut inflammation, although their effect on regulating inflammation-driven angiogenesis is unknown. The present study evaluated the role of the CD40-CD40L interaction in the promotion of immune-mediated angiogenesis in IBD. Methods: Human nonimmune cells of colonic origin—namely, human intestinal fibroblasts (HIFs) and human intestinal microvascular endothelial cells (HIMECs)—were activated with either soluble CD40L (sCD40L), or CD40+ D1.1 cells or CD40L-activated lamina propria T (LPT) cells before measuring pro-angiogenic cytokine release. Blocking antibodies to either CD40 or CD40L were used to disrupt the CD4C)-CD40L interaction. The dextran sodium sulphate (DSS) model of experimental colitis in CD40 and CD40L knockout mice was established to assess whether the CD40-CD40L pathway was implicated in controlling inflammation-driven angiogenesis in vivo. Results: Engagement of CD40 on HIFs promoted the release of vascular endothelial growth factor (VEGF), interleukin-8 (IL-8) and hepatocyte growth factor (HGF). LPT cells were potent inducers of pro-angiogenic cytokine secretion by HIFs. Supernatants from sCD40L-activated HIFs induced migration of HIMECs and tubule formation, both of which were inhibited by blocking antibodies to either VEGF, IL-8 or HGF. Both CD40- and CD40L-deficient mice were protected from DSS-induced colitis and displayed a significant impairment of gut inflammation-driven angiogenesis, as assessed by microvascular density. Conclusions: The CD40-CD40L pathway appears to be crucially involved in regulating inflammation-driven angiogenesis, suggesting that strategies aimed at blocking CD40-CD40L interactions might be beneficial in acute and chronic intestinal injury.


Related Articles

  • Plasma levels of soluble CD40 ligand are elevated in inflammatory bowel diseases. Ludwiczek, O.; Kaser, A.; Tilg, H. // International Journal of Colorectal Disease;Mar2003, Vol. 18 Issue 2, p142 

    Background and aims. CD40/CD40 ligand (CD40L) interaction is important for induction of T cell dependent antibody production and cell-mediated immune responses. Overexpression of CD40/CD40L in the intestinal mucosa is likely to be involved in the pathogenesis of inflammatory bowel disease (IBD)....

  • Fecal Eosinophil Granule-Derived Proteins Reflect Disease Activity in Inflammatory Bowel Disease. Saitoh, Osamu; Kojima, Keishi; Sugi, Kazunori; Matsuse, Ryoichi; Uchida, Kazuo; Tabata, Kazue; Nakagawa, Ken; Kayazawa, Masanobu; Hirata, Ichiro; Katsu, Ken-ichi // American Journal of Gastroenterology;Dec1999, Vol. 94 Issue 12, p3513 

    OBJECTIVES: The aims of this study were: 1) to examine whether the fecal levels of eosinophil granule-derived proteins reflect disease activity in inflammatory bowel disease (IBD); and 2) to examine the extracellular release of these proteins from eosinophils and their stability in feces by an...

  • Serum tenascin-C is an indicator of inflammatory bowel disease activity. Riedl, Stefan; Tandara, Andrea; Reinshagen, Max; Hinz, Ulf; Faissner, Andreas; Bodenmüller, Heinz; Buhr, Heinz J.; Herfarth, Christian; Möller, Peter // International Journal of Colorectal Disease;Sep2001, Vol. 16 Issue 5, p285 

    Tenascin-C is a multifunctional matrix protein that is induced in inflammation and neoplasia. In the colonic mucosa of ulcerative colitis patients tenascin-C indicates tissue repair, and mucosal concentrations are correlated with local disease activity. We prospectively examined the relationship...

  • Role of alkaline phosphatase in colitis in man and rats. A Tuin // Gut;Mar2009, Vol. 58 Issue 3, p379 

    BACKGROUND AND AIMS: Crohn’s disease (CD) and ulcerative colitis (UC) are chronic multifactorial inflammatory bowel diseases (IBDs) with unknown aetiology, but a deregulated mucosal immune response to gut-derived bacterial antigens is thought to be involved. Toll-like receptor ligands,...

  • Molecular prediction of disease risk and severity in a large Dutch Crohn’s disease cohort. R K Weersma // Gut;Mar2009, Vol. 58 Issue 3, p388 

    BACKGROUND: Crohn’s disease and ulcerative colitis have a complex genetic background. We assessed the risk for both the development and severity of the disease by combining information from genetic variants associated with inflammatory bowel disease (IBD). METHODS: We studied 2804...

  • Dysbiosis in inflammatory bowel disease. Tamboli C P; Neut C; Desreumaux P; Colombel J F // Gut;Jan2004, Vol. 53 Issue 1, p1 

    Abundant data have incriminated intestinal bacteria in the initiation and amplification stages of inflammatory bowel diseases. However, the precise role of intestinal bacteria remains elusive. One theory has suggested a breakdown in the balance between putative species of "protective" versus...

  • Inflammatory Bowel Disease in Kuwait. Al-Nakib, B.; Radhakrishnan, S.; Jacob, G. S.; Al-Liddawi, H.; Al-Ruwaih, A. // American Journal of Gastroenterology;Mar1984, Vol. 79 Issue 3, p191 

    Inflammatory bowel disease is considered to be rare or nonexistent in some Arab countries. During a period of 6 years, 91 patients with ulcerative colitis and 17 with Crohn's disease were seen for initial diagnosis in the Gastroenterology Department of Amiri Hospital, which serves 55% of the...

  • VEGF-A isoform modulation in an preclinical TNBS model of ulcerative colitis: protective effects of a VEGF164b therapy. Cromer, Walter E.; Ganta, Chaitanya V.; Patel, Mihir; Traylor, James; Kevil, Christopher G.; Alexander, J. Steven; Mathis, J. Michael // Journal of Translational Medicine;2013, Vol. 11 Issue 1, p1 

    Background: Ulcerative colitis (UC) is the most common form of inflammatory bowel disease in the USA. A key component of UC is the increase in inflammatory angiogenesis of the colon during active disease. This increase is driven to a great extent by the over expression of VEGF-A. Recently,...

  • Alleviation of Experimental Ulcerative Colitis with the Synthetic Peptide, F2A4-K-NS (Fibratide). Xinhua Lin; Paul Zamora; Kazu Takahashi; Yi Lui // Digestive Diseases & Sciences;Sep2007, Vol. 52 Issue 9, p2054 

    Abstract  Recombinant fibroblast growth factors (FGFs) maintain the integrity of the gut epithelium and reduce mucosal injury in experimental inflammatory bowel disease (IBD). Chemically synthesized FGF mimetics could potentially extend the utility of FGFs by tailoring them for...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics